Position in ROIV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$158,316,386
+$133,638,456 QoQ
Shares Held
4,473,478
+402.1% QoQ
Ownership
0.619%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
#28
of 489 holders
Holding Since
Jun 2022
12 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ROIV Over Time
Shares Held
Position Value (USD)
Derivatives in ROIV
reported options exposure · as of Jun 30, 2026CallValue
$555,623
CallShares
15,700
PutValue
$233,574
PutShares
6,600
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Point72 Asset Management, L.P. holds $2,243,264,515 across 171 Biotechnology names. ROIV ranks #1 (7.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
This page
|
4,473,478 | $158,316,386 | |
| 2 | CYTK |
Cytokinetics Inc
|
1,587,712 | $135,257,185 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
1,525,782 | $113,640,243 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
416,516 | $101,950,621 | |
| 5 | LEGN |
Legend Biotech Corp
|
3,076,124 | $88,838,461 | |
| 6 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
137,029 | $73,577,721 | |
| 7 | CELC |
Celcuity Inc.
|
650,916 | $68,098,831 | |
| 8 | ACAD |
Acadia Pharmaceuticals Inc
|
2,433,168 | $61,559,150 |
All Filings in ROIV
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $158,316,386 | 4,473,478 | Shares | Defined | 2026-08-14 | |
| 2026-06-30 | $555,623 | 15,700 | Call | Defined | 2026-08-14 | |
| 2026-06-30 | $233,574 | 6,600 | Put | Defined | 2026-08-14 | |
| 2026-03-31 | $1,016,590 | 36,700 | Call | Defined | 2026-05-15 | |
| 2026-03-31 | $24,677,930 | 890,900 | Shares | Defined | 2026-05-15 | |
| 2026-03-31 | $1,312,980 | 47,400 | Put | Defined | 2026-05-15 | |
| 2025-12-31 | $1,510,320 | 69,600 | Call | Defined | 2026-02-17 | |
| 2025-12-31 | $694,400 | 32,000 | Put | Defined | 2026-02-17 | |
| 2025-09-30 | $39,463,488 | 2,608,294 | Shares | Defined | 2025-11-14 | |
| 2025-09-30 | $6,808,500 | 450,000 | Put | Defined | 2025-11-14 | |
| 2025-06-30 | $33,259,257 | 2,951,132 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $6,198,438 | 614,315 | Shares | Defined | 2025-07-21 | |
| 2024-06-30 | $6,840,121 | 647,126 | Shares | Defined | 2024-09-16 | |
| 2024-03-31 | $4,868,426 | 461,900 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $4,870,451 | 433,700 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $31,610,752 | 2,706,400 | Shares | Defined | 2023-11-14 | |
| 2022-12-31 | $4,608,632 | 576,800 | Shares | Defined | 2023-05-15 | |
| 2022-06-30 | $3,569,373 | 876,996 | Shares | Defined | 2022-08-15 | |
| No filing history on record for this holder in this stock. | ||||||